The Biopharmaceutical market, valued at USD 333 billion in 2022, is on a significant growth trajectory. Forecasts predict that the market will expand to USD 854.6 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.5% from 2023 to 2030. Biopharmaceuticals, which include a wide range of products such as monoclonal antibodies, vaccines, recombinant proteins, and gene therapies,...